What is the best approach for a 22-year-old female with insomnia (inability to sleep), sleeping 5-6 hours per night, who has tried melatonin (a hormone that regulates sleep) and is now requesting sleeping medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Approach to a 22-Year-Old Female with Insomnia Requesting Sleep Medication

Before prescribing any sleep medication, you must first implement Cognitive Behavioral Therapy for Insomnia (CBT-I), which is the gold standard initial treatment for chronic insomnia and demonstrates superior long-term efficacy compared to medications. 1, 2

Step 1: Assess Whether This Is Actually Insomnia Requiring Treatment

5-6 hours of sleep may be sufficient for some young adults, and treatment should only be pursued if there is daytime impairment. Evaluate for:

  • Daytime consequences: fatigue, difficulty concentrating, mood changes, impaired work/school performance 1
  • Sleep onset difficulty (taking >30 minutes to fall asleep) versus sleep maintenance problems (waking during the night) 1
  • Duration: symptoms present for at least 3 months occurring at least 3 nights per week 1
  • Underlying causes: depression, anxiety, substance use, medical conditions, medications, sleep apnea, restless legs syndrome 1, 2

Require a 2-week sleep diary documenting bedtime, wake time, sleep latency, nighttime awakenings, total sleep time, daytime napping, caffeine/alcohol use, and stress levels before proceeding 2

Step 2: Implement CBT-I First (Not Optional)

CBT-I must be initiated before or alongside any pharmacotherapy—this is non-negotiable per guidelines. 1, 2 CBT-I can be delivered through individual therapy, group sessions, telephone-based programs, web-based modules, or self-help books—all formats show effectiveness. 2

Core CBT-I Components to Implement:

Stimulus Control Therapy 1:

  • Go to bed only when sleepy
  • Use bed only for sleep and sex (no TV, phone, reading, work)
  • If unable to sleep within 20 minutes, leave bedroom and return only when drowsy
  • Wake at same time every morning regardless of sleep obtained
  • No daytime napping (or limit to 30 minutes before 2pm)

Sleep Restriction Therapy 1:

  • Calculate average total sleep time from sleep diary (e.g., 5.5 hours)
  • Restrict time in bed to match total sleep time (minimum 5 hours)
  • Increase time in bed by 15-20 minutes weekly if sleep efficiency >85%
  • Decrease time in bed by 15-20 minutes if sleep efficiency <80%

Sleep Hygiene 1, 2:

  • Regular exercise (not within 2 hours of bedtime)
  • Avoid caffeine after noon, no nicotine or alcohol in evening
  • Keep bedroom cool, dark, quiet
  • No screens 30-60 minutes before bed
  • Hot bath 90 minutes before bedtime

Relaxation Training 1:

  • Progressive muscle relaxation
  • Diaphragmatic breathing exercises
  • Guided imagery

Cognitive Restructuring 1:

  • Address beliefs like "I can't sleep without medication" or "My life will be ruined if I can't sleep"

Step 3: If CBT-I Alone Is Insufficient After 4-6 Weeks, Add Pharmacotherapy

For Sleep Onset Insomnia (Difficulty Falling Asleep):

First-line options 1, 2:

  • Zolpidem 5 mg (lower dose for women per FDA) taken immediately before bed with 7-8 hours remaining for sleep 1, 3
  • Ramelteon 8 mg taken 30 minutes before bed—this is non-controlled with no abuse potential, making it ideal for young patients 1, 2, 4
  • Zaleplon 10 mg for sleep onset only 1, 2

For Sleep Maintenance Insomnia (Waking During Night):

First-line options 1, 2:

  • Eszopiclone 2-3 mg for both sleep onset and maintenance 1
  • Zolpidem 5 mg (also effective for maintenance) 1
  • Low-dose doxepin 3-6 mg specifically for sleep maintenance 1, 4

Why Melatonin Failed:

The American Academy of Sleep Medicine explicitly recommends against melatonin for chronic insomnia due to insufficient evidence of efficacy. 1 Over-the-counter melatonin supplements lack standardization, have short half-lives, and studies show only 9-minute reduction in sleep latency compared to placebo. 1, 5

Step 4: Medication Selection Algorithm

Choose based on specific sleep complaint pattern:

  1. If primary complaint is falling asleep: Start ramelteon 8 mg (safest, non-controlled) or zolpidem 5 mg 1, 2, 4
  2. If primary complaint is staying asleep: Start eszopiclone 2 mg or doxepin 3 mg 1, 4
  3. If both onset and maintenance problems: Start eszopiclone 2 mg or zolpidem 5 mg 1

Prescribe for short-term use only (4-5 weeks maximum initially) with plan for reassessment. 1, 3 Medication should supplement, not replace, ongoing CBT-I. 1, 2

Critical Safety Counseling Required:

  • Take medication only when able to dedicate 7-8 hours to sleep 3
  • Do not take with or after meals (delays absorption) 3
  • Risk of next-morning impairment of driving and activities requiring alertness 3
  • Risk of complex sleep behaviors (sleep-walking, sleep-driving)—stop medication immediately if these occur 1, 2
  • No alcohol or other CNS depressants 3
  • Reassess after 1-2 weeks for efficacy and side effects 2

Common Pitfalls to Avoid:

  • Prescribing medication without implementing CBT-I first—this violates guideline recommendations and leads to worse long-term outcomes 1, 2
  • Using diphenhydramine or other antihistamines—explicitly not recommended due to lack of efficacy, rapid tolerance (3-4 days), and anticholinergic effects 1, 4
  • Prescribing trazodone—explicitly not recommended by guidelines despite common off-label use 1, 4
  • Continuing medication long-term without reassessment—insomnia persisting beyond 7-10 days requires evaluation for underlying sleep disorders like sleep apnea 2
  • Assuming 5-6 hours requires treatment—only treat if daytime impairment is present 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pharmacotherapy of Insomnia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Non-Controlled, Non-Habit-Forming Medications for Insomnia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Melatonin and its analogs in insomnia and depression.

Journal of pineal research, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.